Alnylam announces 2020 product and pipeline goals

Alnylam pharmaceuticals inc - announces 2020 product and pipeline goals and provides updates at research and development day.alnylam pharmaceuticals inc - expects to exceed alnylam 2020 goals with four marketed products, 14 organic clinical stage programs by end of 2020.alnylam pharmaceuticals - plans to get approval of onpattro in brazil in mid-2020, with planned launches in additional countries throughout 2020.alnylam pharmaceuticals - plans to achieve regulatory approval from european medicines agency in early 2020 for givlaari.alnylam pharmaceuticals inc - plans to report topline results from illuminate-b pediatric phase 3 study in mid-2020.alnylam pharmaceuticals inc - plans to support medicines company's efforts with respect to orion phase 3 studies of inclisiran.
ALNY Ratings Summary
ALNY Quant Ranking